Current Use and Trends in Unprotected Left Main Coronary Artery Percutaneous Intervention

go back to reference Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124(23):e574–651.PubMed Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124(23):e574–651.PubMed

go back to reference Takaro T, Peduzzi P, Detre KM, Hultgren HN, Murphy ML, van der Bel-Kahn J, et al. Survival in subgroups of patients with left main coronary artery disease. Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease. Circulation. 1982;66(1):14–22.CrossRefPubMed Takaro T, Peduzzi P, Detre KM, Hultgren HN, Murphy ML, van der Bel-Kahn J, et al. Survival in subgroups of patients with left main coronary artery disease. Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease. Circulation. 1982;66(1):14–22.CrossRefPubMed

go back to reference Ragosta M, Dee S, Sarembock IJ, Lipson LC, Gimple LW, Powers ER. Prevalence of unfavorable angiographic characteristics for percutaneous intervention in patients with unprotected left main coronary artery disease. Catheter Cardiovasc Interv. 2006;68(3):357–62.CrossRefPubMed Ragosta M, Dee S, Sarembock IJ, Lipson LC, Gimple LW, Powers ER. Prevalence of unfavorable angiographic characteristics for percutaneous intervention in patients with unprotected left main coronary artery disease. Catheter Cardiovasc Interv. 2006;68(3):357–62.CrossRefPubMed

go back to reference Taggart DP, Kaul S, Boden WE, Ferguson TB Jr, Guyton RA, Mack MJ, et al. Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery. J Am Coll Cardiol. 2008;51(9):885–92.CrossRefPubMed Taggart DP, Kaul S, Boden WE, Ferguson TB Jr, Guyton RA, Mack MJ, et al. Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery. J Am Coll Cardiol. 2008;51(9):885–92.CrossRefPubMed

go back to reference Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961–72.CrossRefPubMed Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961–72.CrossRefPubMed

go back to reference El-Menyar AA, Al Suwaidi J, Holmes DR Jr. Left main coronary artery stenosis: state-of-the-art. Curr Probl Cardiol. 2007;32(3):103–93.CrossRefPubMed El-Menyar AA, Al Suwaidi J, Holmes DR Jr. Left main coronary artery stenosis: state-of-the-art. Curr Probl Cardiol. 2007;32(3):103–93.CrossRefPubMed

go back to reference Rastan AJ, Boudriot E, Falk V, Kappetein AP, Borger MA, Serruys PW, et al. Frequency and pattern of de-novo three-vessel and left main coronary artery disease; insights from single center enrolment in the SYNTAX study. Eur J Cardiothorac Surg. 2008;34(2):376–82 Discussion 82-3.CrossRefPubMed Rastan AJ, Boudriot E, Falk V, Kappetein AP, Borger MA, Serruys PW, et al. Frequency and pattern of de-novo three-vessel and left main coronary artery disease; insights from single center enrolment in the SYNTAX study. Eur J Cardiothorac Surg. 2008;34(2):376–82 Discussion 82-3.CrossRefPubMed

go back to reference Conley MJ, Ely RL, Kisslo J, Lee KL, McNeer JF, Rosati RA. The prognostic spectrum of left main stenosis. Circulation. 1978;57(5):947–52.CrossRefPubMed Conley MJ, Ely RL, Kisslo J, Lee KL, McNeer JF, Rosati RA. The prognostic spectrum of left main stenosis. Circulation. 1978;57(5):947–52.CrossRefPubMed

go back to reference Thompson R. Isolated coronary ostial stenosis in women. J Am Coll Cardiol. 1986;7(5):997–1003.CrossRefPubMed Thompson R. Isolated coronary ostial stenosis in women. J Am Coll Cardiol. 1986;7(5):997–1003.CrossRefPubMed

go back to reference Jonsson A, Ivert T, Svane B, Liska J, Jakobsson K, Hammar N. Classification of left main coronary obstruction--feasibility of surgical angioplasty and survival after coronary artery bypass surgery. Cardiovasc Surg. 2003;11(6):497–505.CrossRefPubMed Jonsson A, Ivert T, Svane B, Liska J, Jakobsson K, Hammar N. Classification of left main coronary obstruction--feasibility of surgical angioplasty and survival after coronary artery bypass surgery. Cardiovasc Surg. 2003;11(6):497–505.CrossRefPubMed

go back to reference Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet. 2009;373(9670):1190–7.CrossRefPubMed Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet. 2009;373(9670):1190–7.CrossRefPubMed

go back to reference Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation. 2008;118(11):1146–54.CrossRefPubMed Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation. 2008;118(11):1146–54.CrossRefPubMed

go back to reference Stefanini GG, Holmes DR Jr. Drug-eluting coronary-artery stents. N Engl J Med. 2013;368(3):254–65.CrossRefPubMed Stefanini GG, Holmes DR Jr. Drug-eluting coronary-artery stents. N Engl J Med. 2013;368(3):254–65.CrossRefPubMed

go back to reference •• Makikallio T, Holm NR, Lindsay M, Spence MS, Erglis A, Menown IB, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet. 2016;388(10061):2743–52 This trial showed that LM PCI as an option was inferior to CABG in a northern European population which was in contrast to the EXCEL trial. It also showed that patients with intermediate to high SYNTAX scores did better than those treated with CABG, whereas in those with low SYNTAX scores, CABG was a better option.CrossRefPubMed •• Makikallio T, Holm NR, Lindsay M, Spence MS, Erglis A, Menown IB, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet. 2016;388(10061):2743–52 This trial showed that LM PCI as an option was inferior to CABG in a northern European population which was in contrast to the EXCEL trial. It also showed that patients with intermediate to high SYNTAX scores did better than those treated with CABG, whereas in those with low SYNTAX scores, CABG was a better option.CrossRefPubMed

go back to reference Lindstaedt M, Spiecker M, Lawo T, Yazar A, Mugge A, Bojara W, et al. Angiographic assessment of functionally insignificant left main coronary artery stenoses: reliability compared to intracoronary pressure measurement. Dtsch Med Wochenschr. 2006;131(39):2134–8.CrossRefPubMed Lindstaedt M, Spiecker M, Lawo T, Yazar A, Mugge A, Bojara W, et al. Angiographic assessment of functionally insignificant left main coronary artery stenoses: reliability compared to intracoronary pressure measurement. Dtsch Med Wochenschr. 2006;131(39):2134–8.CrossRefPubMed

go back to reference Lindstaedt M, Spiecker M, Perings C, Lawo T, Yazar A, Holland-Letz T, et al. How good are experienced interventional cardiologists at predicting the functional significance of intermediate or equivocal left main coronary artery stenoses? Int J Cardiol. 2007;120(2):254–61.CrossRefPubMed Lindstaedt M, Spiecker M, Perings C, Lawo T, Yazar A, Holland-Letz T, et al. How good are experienced interventional cardiologists at predicting the functional significance of intermediate or equivocal left main coronary artery stenoses? Int J Cardiol. 2007;120(2):254–61.CrossRefPubMed

go back to reference Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Chuang YC, et al. Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions. Circulation. 1995;91(7):1959–65.CrossRefPubMed Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Chuang YC, et al. Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions. Circulation. 1995;91(7):1959–65.CrossRefPubMed

go back to reference Hamilos M, Muller O, Cuisset T, Ntalianis A, Chlouverakis G, Sarno G, et al. Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis. Circulation. 2009;120(15):1505–12.CrossRefPubMed Hamilos M, Muller O, Cuisset T, Ntalianis A, Chlouverakis G, Sarno G, et al. Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis. Circulation. 2009;120(15):1505–12.CrossRefPubMed

go back to reference Arnett EN, Isner JM, Redwood DR, Kent KM, Baker WP, Ackerstein H, et al. Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. Ann Intern Med. 1979;91(3):350–6.CrossRefPubMed Arnett EN, Isner JM, Redwood DR, Kent KM, Baker WP, Ackerstein H, et al. Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. Ann Intern Med. 1979;91(3):350–6.CrossRefPubMed

go back to reference Leesar MA, Masden R, Jasti V. Physiological and intravascular ultrasound assessment of an ambiguous left main coronary artery stenosis. Catheter Cardiovasc Interv. 2004;62(3):349–57.CrossRefPubMed Leesar MA, Masden R, Jasti V. Physiological and intravascular ultrasound assessment of an ambiguous left main coronary artery stenosis. Catheter Cardiovasc Interv. 2004;62(3):349–57.CrossRefPubMed

go back to reference Dato I, Burzotta F, Trani C, Romano A, Paraggio L, Aurigemma C, et al. Optical coherence tomography guidance for the management of angiographically intermediate left main bifurcation lesions: early clinical experience. Int J Cardiol. 2017;248:108–13.CrossRefPubMed Dato I, Burzotta F, Trani C, Romano A, Paraggio L, Aurigemma C, et al. Optical coherence tomography guidance for the management of angiographically intermediate left main bifurcation lesions: early clinical experience. Int J Cardiol. 2017;248:108–13.CrossRefPubMed

go back to reference Jasti V, Ivan E, Yalamanchili V, Wongpraparut N, Leesar MA. Correlations between fractional flow reserve and intravascular ultrasound in patients with an ambiguous left main coronary artery stenosis. Circulation. 2004;110(18):2831–6.CrossRefPubMed Jasti V, Ivan E, Yalamanchili V, Wongpraparut N, Leesar MA. Correlations between fractional flow reserve and intravascular ultrasound in patients with an ambiguous left main coronary artery stenosis. Circulation. 2004;110(18):2831–6.CrossRefPubMed

go back to reference Bech GJ, Droste H, Pijls NH, De Bruyne B, Bonnier JJ, Michels HR, et al. Value of fractional flow reserve in making decisions about bypass surgery for equivocal left main coronary artery disease. Heart. 2001;86(5):547–52.CrossRefPubMedPubMedCentral Bech GJ, Droste H, Pijls NH, De Bruyne B, Bonnier JJ, Michels HR, et al. Value of fractional flow reserve in making decisions about bypass surgery for equivocal left main coronary artery disease. Heart. 2001;86(5):547–52.CrossRefPubMedPubMedCentral

go back to reference Suemaru S, Iwasaki K, Yamamoto K, Kusachi S, Hina K, Hirohata S, et al. Coronary pressure measurement to determine treatment strategy for equivocal left main coronary artery lesions. Heart Vessel. 2005;20(6):271–7.CrossRef Suemaru S, Iwasaki K, Yamamoto K, Kusachi S, Hina K, Hirohata S, et al. Coronary pressure measurement to determine treatment strategy for equivocal left main coronary artery lesions. Heart Vessel. 2005;20(6):271–7.CrossRef

go back to reference Legutko J, Dudek D, Rzeszutko L, Wizimirski M, Dubiel JS. Fractional flow reserve assessment to determine the indications for myocardial revascularisation in patients with borderline stenosis of the left main coronary artery. Kardiol Pol. 2005;63(5):499–506 Discussion 7-8.PubMed Legutko J, Dudek D, Rzeszutko L, Wizimirski M, Dubiel JS. Fractional flow reserve assessment to determine the indications for myocardial revascularisation in patients with borderline stenosis of the left main coronary artery. Kardiol Pol. 2005;63(5):499–506 Discussion 7-8.PubMed

go back to reference Courtis J, Rodes-Cabau J, Larose E, Potvin JM, Dery JP, Larochelliere RD, et al. Usefulness of coronary fractional flow reserve measurements in guiding clinical decisions in intermediate or equivocal left main coronary stenoses. Am J Cardiol. 2009;103(7):943–9.CrossRefPubMed Courtis J, Rodes-Cabau J, Larose E, Potvin JM, Dery JP, Larochelliere RD, et al. Usefulness of coronary fractional flow reserve measurements in guiding clinical decisions in intermediate or equivocal left main coronary stenoses. Am J Cardiol. 2009;103(7):943–9.CrossRefPubMed

go back to reference Adjedj J, De Bruyne B, Flore V, Di Gioia G, Ferrara A, Pellicano M, et al. Significance of intermediate values of fractional flow reserve in patients with coronary artery disease. Circulation. 2016;133(5):502–8.CrossRefPubMed Adjedj J, De Bruyne B, Flore V, Di Gioia G, Ferrara A, Pellicano M, et al. Significance of intermediate values of fractional flow reserve in patients with coronary artery disease. Circulation. 2016;133(5):502–8.CrossRefPubMed

go back to reference Fearon WF, Yong AS, Lenders G, Toth GG, Dao C, Daniels DV, et al. The impact of downstream coronary stenosis on fractional flow reserve assessment of intermediate left main coronary artery disease: human validation. JACC Cardiovasc Interv. 2015;8(3):398–403.CrossRefPubMed Fearon WF, Yong AS, Lenders G, Toth GG, Dao C, Daniels DV, et al. The impact of downstream coronary stenosis on fractional flow reserve assessment of intermediate left main coronary artery disease: human validation. JACC Cardiovasc Interv. 2015;8(3):398–403.CrossRefPubMed

go back to reference Gotberg M, Frobert O. Instantaneous wave-free ratio versus fractional flow reserve. N Engl J Med. 2017;377(16):1596–7.PubMed Gotberg M, Frobert O. Instantaneous wave-free ratio versus fractional flow reserve. N Engl J Med. 2017;377(16):1596–7.PubMed

go back to reference Davies JE, Sen S, Dehbi HM, Al-Lamee R, Petraco R, Nijjer SS, et al. Use of the instantaneous wave-free ratio or fractional flow reserve in PCI. N Engl J Med. 2017;376(19):1824–34.CrossRefPubMed Davies JE, Sen S, Dehbi HM, Al-Lamee R, Petraco R, Nijjer SS, et al. Use of the instantaneous wave-free ratio or fractional flow reserve in PCI. N Engl J Med. 2017;376(19):1824–34.CrossRefPubMed

go back to reference Salvatore De Rosa AP, De Velli G, Conte M, Sabato Sorrentino CS, Mongiardo A, Sabatino J, Contarini M , Todaroand D, Indolfi C Reliability of instantaneous wave-free ratio (iFR) for the evaluation of left main coronary artery lesions. J Clin Med. 2019;8. Salvatore De Rosa AP, De Velli G, Conte M, Sabato Sorrentino CS, Mongiardo A, Sabatino J, Contarini M , Todaroand D, Indolfi C Reliability of instantaneous wave-free ratio (iFR) for the evaluation of left main coronary artery lesions. J Clin Med. 2019;8.

go back to reference Norgaard BL, Terkelsen CJ, Mathiassen ON, Grove EL, Botker HE, Parner E, et al. Coronary CT angiographic and flow reserve-guided management of patients with stable ischemic heart disease. J Am Coll Cardiol. 2018;72(18):2123–34.CrossRefPubMed Norgaard BL, Terkelsen CJ, Mathiassen ON, Grove EL, Botker HE, Parner E, et al. Coronary CT angiographic and flow reserve-guided management of patients with stable ischemic heart disease. J Am Coll Cardiol. 2018;72(18):2123–34.CrossRefPubMed

go back to reference de la Torre Hernandez JM, Baz Alonso JA, Gomez Hospital JA, Alfonso Manterola F, Garcia Camarero T, Gimeno de Carlos F, et al. Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries. JACC Cardiovasc Interv. 2014;7(3):244–54.CrossRefPubMed de la Torre Hernandez JM, Baz Alonso JA, Gomez Hospital JA, Alfonso Manterola F, Garcia Camarero T, Gimeno de Carlos F, et al. Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries. JACC Cardiovasc Interv. 2014;7(3):244–54.CrossRefPubMed

go back to reference Park SJ, Kim YH, Park DW, Lee SW, Kim WJ, Suh J, et al. Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv. 2009;2(3):167–77.CrossRefPubMed Park SJ, Kim YH, Park DW, Lee SW, Kim WJ, Suh J, et al. Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv. 2009;2(3):167–77.CrossRefPubMed

go back to reference Zhang J, Gao X, Kan J, Ge Z, Han L, Lu S, et al. Intravascular ultrasound versus angiography-guided drug-eluting stent implantation: the ULTIMATE trial. J Am Coll Cardiol. 2018;72(24):3126–37.CrossRefPubMed Zhang J, Gao X, Kan J, Ge Z, Han L, Lu S, et al. Intravascular ultrasound versus angiography-guided drug-eluting stent implantation: the ULTIMATE trial. J Am Coll Cardiol. 2018;72(24):3126–37.CrossRefPubMed

go back to reference Abizaid AS, Mintz GS, Abizaid A, Mehran R, Lansky AJ, Pichard AD, et al. One-year follow-up after intravascular ultrasound assessment of moderate left main coronary artery disease in patients with ambiguous angiograms. J Am Coll Cardiol. 1999;34(3):707–15.CrossRefPubMed Abizaid AS, Mintz GS, Abizaid A, Mehran R, Lansky AJ, Pichard AD, et al. One-year follow-up after intravascular ultrasound assessment of moderate left main coronary artery disease in patients with ambiguous angiograms. J Am Coll Cardiol. 1999;34(3):707–15.CrossRefPubMed

go back to reference Fassa AA, Wagatsuma K, Higano ST, Mathew V, Barsness GW, Lennon RJ, et al. Intravascular ultrasound-guided treatment for angiographically indeterminate left main coronary artery disease: a long-term follow-up study. J Am Coll Cardiol. 2005;45(2):204–11.CrossRefPubMed Fassa AA, Wagatsuma K, Higano ST, Mathew V, Barsness GW, Lennon RJ, et al. Intravascular ultrasound-guided treatment for angiographically indeterminate left main coronary artery disease: a long-term follow-up study. J Am Coll Cardiol. 2005;45(2):204–11.CrossRefPubMed

go back to reference Okabe T, Mintz GS, Lee SY, Lee B, Roy P, Steinberg DH, et al. Five-year outcomes of moderate or ambiguous left main coronary artery disease and the intravascular ultrasound predictors of events. J Invasive Cardiol. 2008;20(12):635–9.PubMed Okabe T, Mintz GS, Lee SY, Lee B, Roy P, Steinberg DH, et al. Five-year outcomes of moderate or ambiguous left main coronary artery disease and the intravascular ultrasound predictors of events. J Invasive Cardiol. 2008;20(12):635–9.PubMed

go back to reference Rathod KS, Hamshere SM, Jones DA, Mathur A. Intravascular ultrasound versus optical coherence tomography for coronary artery imaging-apples and oranges? Interv Cardiol. 2015;10(1):8–15.CrossRefPubMedPubMedCentral Rathod KS, Hamshere SM, Jones DA, Mathur A. Intravascular ultrasound versus optical coherence tomography for coronary artery imaging-apples and oranges? Interv Cardiol. 2015;10(1):8–15.CrossRefPubMedPubMedCentral

go back to reference •• Stone GW, Kappetein AP, Sabik JF, Pocock SJ, Morice MC, Puskas J, et al. Five-year outcomes after PCI or CABG for left main coronary disease. N Engl J Med. 2019; An important trial determining the safety and feasibility of left main coronary artery PCI, and this trial also showed that LM PCI was non-inferior to CABG over a period of 5 years. •• Stone GW, Kappetein AP, Sabik JF, Pocock SJ, Morice MC, Puskas J, et al. Five-year outcomes after PCI or CABG for left main coronary disease. N Engl J Med. 2019; An important trial determining the safety and feasibility of left main coronary artery PCI, and this trial also showed that LM PCI was non-inferior to CABG over a period of 5 years.

go back to reference Buszman PE, Buszman PP, Banasiewicz-Szkrobka I, Milewski KP, Zurakowski A, Orlik B, et al. Left main stenting in comparison with surgical revascularization: 10-year outcomes of the (left main coronary artery stenting) LE MANS trial. JACC Cardiovasc Interv. 2016;9(4):318–27.CrossRefPubMed Buszman PE, Buszman PP, Banasiewicz-Szkrobka I, Milewski KP, Zurakowski A, Orlik B, et al. Left main stenting in comparison with surgical revascularization: 10-year outcomes of the (left main coronary artery stenting) LE MANS trial. JACC Cardiovasc Interv. 2016;9(4):318–27.CrossRefPubMed

go back to reference Buszman PE, Buszman PP, Kiesz RS, Bochenek A, Trela B, Konkolewska M, et al. Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (left main coronary artery stenting) registry. J Am Coll Cardiol. 2009;54(16):1500–11.CrossRefPubMed Buszman PE, Buszman PP, Kiesz RS, Bochenek A, Trela B, Konkolewska M, et al. Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (left main coronary artery stenting) registry. J Am Coll Cardiol. 2009;54(16):1500–11.CrossRefPubMed

go back to reference Buszman PE, Kiesz SR, Bochenek A, Peszek-Przybyla E, Szkrobka I, Debinski M, et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol. 2008;51(5):538–45.CrossRefPubMed Buszman PE, Kiesz SR, Bochenek A, Peszek-Przybyla E, Szkrobka I, Debinski M, et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol. 2008;51(5):538–45.CrossRefPubMed

go back to reference Boudriot E, Thiele H, Walther T, Liebetrau C, Boeckstegers P, Pohl T, et al. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J Am Coll Cardiol. 2011;57(5):538–45.CrossRefPubMed Boudriot E, Thiele H, Walther T, Liebetrau C, Boeckstegers P, Pohl T, et al. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J Am Coll Cardiol. 2011;57(5):538–45.CrossRefPubMed

go back to reference Ahn JM, Roh JH, Kim YH, Park DW, Yun SC, Lee PH, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease: 5-year outcomes of the PRECOMBAT study. J Am Coll Cardiol. 2015;65(20):2198–206.CrossRefPubMed Ahn JM, Roh JH, Kim YH, Park DW, Yun SC, Lee PH, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease: 5-year outcomes of the PRECOMBAT study. J Am Coll Cardiol. 2015;65(20):2198–206.CrossRefPubMed

go back to reference Park SJ, Kim YH, Park DW, Yun SC, Ahn JM, Song HG, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med. 2011;364(18):1718–27.CrossRefPubMed Park SJ, Kim YH, Park DW, Yun SC, Ahn JM, Song HG, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med. 2011;364(18):1718–27.CrossRefPubMed

go back to reference Morice MC, Serruys PW, Kappetein AP, Feldman TE, Stahle E, Colombo A, et al. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. Circulation. 2014;129(23):2388–94.CrossRefPubMed Morice MC, Serruys PW, Kappetein AP, Feldman TE, Stahle E, Colombo A, et al. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. Circulation. 2014;129(23):2388–94.CrossRefPubMed

go back to reference •• Morice MC, Serruys PW, Kappetein AP, Feldman TE, Stahle E, Colombo A, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation. 2010;121(24):2645–53 This trial forms the backbone of all soceital guideline recommendations which are currently followed by major professional cardiology and cardiothoracic surgery societies worldwide.CrossRefPubMed •• Morice MC, Serruys PW, Kappetein AP, Feldman TE, Stahle E, Colombo A, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation. 2010;121(24):2645–53 This trial forms the backbone of all soceital guideline recommendations which are currently followed by major professional cardiology and cardiothoracic surgery societies worldwide.CrossRefPubMed

go back to reference Stone GW, Sabik JF, Serruys PW, Simonton CA, Genereux P, Puskas J, et al. Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med. 2016;375(23):2223–35.CrossRefPubMed Stone GW, Sabik JF, Serruys PW, Simonton CA, Genereux P, Puskas J, et al. Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med. 2016;375(23):2223–35.CrossRefPubMed

go back to reference En Chen WC, Chen L-l. Crush versus culotte stenting techniques for coronary bifurcation lesions A systematic review and meta-analysis of clinical trials with long-term follow-up. Medicine. 2019;98. En Chen WC, Chen L-l. Crush versus culotte stenting techniques for coronary bifurcation lesions A systematic review and meta-analysis of clinical trials with long-term follow-up. Medicine. 2019;98.

go back to reference Chen SL, Zhang JJ, Han Y, Kan J, Chen L, Qiu C, et al. Double kissing crush versus provisional stenting for left main distal bifurcation lesions: DKCRUSH-V randomized trial. J Am Coll Cardiol. 2017;70(21):2605–17.CrossRefPubMed Chen SL, Zhang JJ, Han Y, Kan J, Chen L, Qiu C, et al. Double kissing crush versus provisional stenting for left main distal bifurcation lesions: DKCRUSH-V randomized trial. J Am Coll Cardiol. 2017;70(21):2605–17.CrossRefPubMed

go back to reference Chen SL, Xu B, Han YL, Sheiban I, Zhang JJ, Ye F, et al. Clinical outcome after DK crush versus culotte stenting of distal left main bifurcation lesions: the 3-year follow-up results of the DKCRUSH-III study. JACC Cardiovasc Interv. 2015;8(10):1335–42.CrossRefPubMed Chen SL, Xu B, Han YL, Sheiban I, Zhang JJ, Ye F, et al. Clinical outcome after DK crush versus culotte stenting of distal left main bifurcation lesions: the 3-year follow-up results of the DKCRUSH-III study. JACC Cardiovasc Interv. 2015;8(10):1335–42.CrossRefPubMed

go back to reference Gyldenkerne C, Olesen KKW, Jensen LO, Junker A, Veien KT, Terkelsen CJ, et al. Everolimus-eluting versus biolimus-eluting coronary stent implantation in patients with and without diabetes mellitus. Am J Cardiol. 2019;124(5):671–7.CrossRefPubMed Gyldenkerne C, Olesen KKW, Jensen LO, Junker A, Veien KT, Terkelsen CJ, et al. Everolimus-eluting versus biolimus-eluting coronary stent implantation in patients with and without diabetes mellitus. Am J Cardiol. 2019;124(5):671–7.CrossRefPubMed

go back to reference Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC/AHA Guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: an update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF/AHA Guideline for the management of ST-elevation myocardial infarction, 2014 AHA/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC/AHA Guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation. 2016;134(10):e123–55.CrossRefPubMed Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC/AHA Guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: an update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF/AHA Guideline for the management of ST-elevation myocardial infarction, 2014 AHA/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC/AHA Guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation. 2016;134(10):e123–55.CrossRefPubMed

go back to reference Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Thorac Cardiovasc Surg. 2015;149(3):e5–23.CrossRefPubMed Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Thorac Cardiovasc Surg. 2015;149(3):e5–23.CrossRefPubMed

go back to reference Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60(16):1581–98.CrossRefPubMed Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60(16):1581–98.CrossRefPubMed

go back to reference Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018;138(20):e618–e51.CrossRefPubMed Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018;138(20):e618–e51.CrossRefPubMed

go back to reference Cavalcante R, Sotomi Y, Lee CW, Ahn JM, Farooq V, Tateishi H, et al. Outcomes after percutaneous coronary intervention or bypass surgery in patients with unprotected left main disease. J Am Coll Cardiol. 2016;68(10):999–1009.CrossRefPubMed Cavalcante R, Sotomi Y, Lee CW, Ahn JM, Farooq V, Tateishi H, et al. Outcomes after percutaneous coronary intervention or bypass surgery in patients with unprotected left main disease. J Am Coll Cardiol. 2016;68(10):999–1009.CrossRefPubMed

go back to reference Valle JA, Tamez H, Abbott JD, Moussa ID, Messenger JC, Waldo SW, et al. Contemporary use and trends in unprotected left main coronary artery percutaneous coronary intervention in the United States: an analysis of the National Cardiovascular Data Registry Research to practice initiative. JAMA Cardiol. 2019;4(2):100–9.CrossRefPubMedPubMedCentral Valle JA, Tamez H, Abbott JD, Moussa ID, Messenger JC, Waldo SW, et al. Contemporary use and trends in unprotected left main coronary artery percutaneous coronary intervention in the United States: an analysis of the National Cardiovascular Data Registry Research to practice initiative. JAMA Cardiol. 2019;4(2):100–9.CrossRefPubMedPubMedCentral

go back to reference Head SJ, Milojevic M, Daemen J, Ahn JM, Boersma E, Christiansen EH, et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. Lancet. 2018;391(10124):939–48.CrossRefPubMed Head SJ, Milojevic M, Daemen J, Ahn JM, Boersma E, Christiansen EH, et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. Lancet. 2018;391(10124):939–48.CrossRefPubMed

go back to reference Sardar P, Giri J, Elmariah S, Chatterjee S, Kolte D, Kundu A, et al. Meta-analysis of drug-eluting stents versus coronary artery bypass grafting in unprotected left main coronary narrowing. Am J Cardiol. 2017;119(11):1746–52.CrossRefPubMed Sardar P, Giri J, Elmariah S, Chatterjee S, Kolte D, Kundu A, et al. Meta-analysis of drug-eluting stents versus coronary artery bypass grafting in unprotected left main coronary narrowing. Am J Cardiol. 2017;119(11):1746–52.CrossRefPubMed

go back to reference Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165.CrossRefPubMed Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165.CrossRefPubMed

go back to reference Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK, et al. 2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care: endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencionista; affirmation of value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d’intervention. J Am Coll Cardiol. 2015;65(19):2140–1.CrossRefPubMed Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK, et al. 2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care: endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencionista; affirmation of value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d’intervention. J Am Coll Cardiol. 2015;65(19):2140–1.CrossRefPubMed

go back to reference Sukiennik A, Kasprzak M, Mazurek W, Niezgoda P, Bednarczyk L, Kubica J. High-risk percutaneous coronary intervention with Impella CP hemodynamic support. A case series and method presentation. Postepy Kardiol Interwencyjnej. 2017;13(1):67–71.PubMedPubMedCentral Sukiennik A, Kasprzak M, Mazurek W, Niezgoda P, Bednarczyk L, Kubica J. High-risk percutaneous coronary intervention with Impella CP hemodynamic support. A case series and method presentation. Postepy Kardiol Interwencyjnej. 2017;13(1):67–71.PubMedPubMedCentral

go back to reference O’Neill WW, Kleiman NS, Moses J, Henriques JP, Dixon S, Massaro J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation. 2012;126(14):1717–27.CrossRefPubMed O’Neill WW, Kleiman NS, Moses J, Henriques JP, Dixon S, Massaro J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation. 2012;126(14):1717–27.CrossRefPubMed

go back to reference Alazzoni A, Al-Saleh A, Jolly SS. Everolimus-eluting versus paclitaxel-eluting stents in percutaneous coronary intervention: meta-analysis of randomized trials. Thrombosis. 2012;2012:126369. https://doi.org/10.1155/2012/126369 Alazzoni A, Al-Saleh A, Jolly SS. Everolimus-eluting versus paclitaxel-eluting stents in percutaneous coronary intervention: meta-analysis of randomized trials. Thrombosis. 2012;2012:126369. https://​doi.​org/​10.​1155/​2012/​126369

go back to reference Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, et al. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA. 2008;299(16):1903–13.CrossRefPubMed Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, et al. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA. 2008;299(16):1903–13.CrossRefPubMed

go back to reference Colombo A, Bramucci E, Sacca S, Violini R, Lettieri C, Zanini R, et al. Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: the CACTUS (coronary bifurcations: application of the crushing technique using sirolimus-eluting stents) study. Circulation. 2009;119(1):71–8.CrossRefPubMed Colombo A, Bramucci E, Sacca S, Violini R, Lettieri C, Zanini R, et al. Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: the CACTUS (coronary bifurcations: application of the crushing technique using sirolimus-eluting stents) study. Circulation. 2009;119(1):71–8.CrossRefPubMed

go back to reference Maeng M, Holm NR, Erglis A, Kumsars I, Niemela M, Kervinen K, et al. Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: Nordic bifurcation study 5-year follow-up results. J Am Coll Cardiol. 2013;62(1):30–4.CrossRefPubMed Maeng M, Holm NR, Erglis A, Kumsars I, Niemela M, Kervinen K, et al. Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: Nordic bifurcation study 5-year follow-up results. J Am Coll Cardiol. 2013;62(1):30–4.CrossRefPubMed

go back to reference Hildick-Smith D, de Belder AJ, Cooter N, Curzen NP, Clayton TC, Oldroyd KG, et al. Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British bifurcation coronary study: old, new, and evolving strategies. Circulation. 2010;121(10):1235–43.CrossRefPubMed Hildick-Smith D, de Belder AJ, Cooter N, Curzen NP, Clayton TC, Oldroyd KG, et al. Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British bifurcation coronary study: old, new, and evolving strategies. Circulation. 2010;121(10):1235–43.CrossRefPubMed

go back to reference Farooq V, Serruys PW, Garcia-Garcia HM, Zhang Y, Bourantas CV, Holmes DR, et al. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. J Am Coll Cardiol. 2013;61(3):282–94.CrossRefPubMed Farooq V, Serruys PW, Garcia-Garcia HM, Zhang Y, Bourantas CV, Holmes DR, et al. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. J Am Coll Cardiol. 2013;61(3):282–94.CrossRefPubMed

go back to reference Clark RE, The STS. Cardiac Surgery National Database: an update. Ann Thorac Surg. 1995;59(6):1376–80 Discussion 80-1.CrossRefPubMed Clark RE, The STS. Cardiac Surgery National Database: an update. Ann Thorac Surg. 1995;59(6):1376–80 Discussion 80-1.CrossRefPubMed